High Dose of Lamivudine and Resistance in Patients with Chronic Hepatitis B

Background. Lamivudine is the most affordable drug used for chronic hepatitis B and has a high safety profile. With the daily dose of 100 mg there is progressive appearance of resistance to lamivudine therapy. In our study we used 150 mg of lamivudine daily as a standard dose which warrants further...

Descripción completa

Detalles Bibliográficos
Autores principales: Wani, Hamid Ullah, Al Kaabi, Saad, Sharma, Manik, Singh, Rajvir, John, Anil, Derbala, Moutaz, Al-Mohannadi, Muneera J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199074/
https://www.ncbi.nlm.nih.gov/pubmed/25349729
http://dx.doi.org/10.1155/2014/615621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199074/
https://www.ncbi.nlm.nih.gov/pubmed/25349729
http://dx.doi.org/10.1155/2014/615621

Ejemplares similares